前立腺がん治療の進歩:免疫療法における革新と課題

Gargi Singhal¹, Pankaj Garg², Atish Mohanty³

¹Undergraduate Medical Sciences, S.N. Medical College Agra, Agra, Uttar Pradesh, India.

Cancer treatment and research

|August 23, 2025

まとめ

前立腺がんの免疫療法は免疫システムを活用することで治療に革命を起こしていますイノベーションと組み合わせた戦略は患者にとって持続的な成果を期待できます

科学分野:

腫瘍学
免疫学

背景:

前立腺がん (PCa) は男性における癌による死亡の重要な原因である.
免疫療法の出現は,PCa治療戦略のパラダイムシフトを開始しました.

研究の目的:

前立腺がんの免疫的状況を調べるため
PCaの現在のおよび新興の免疫療法アプローチを強調する.
課題に対処し,効果を高めるための組み合わせ戦略を探求する.

主な方法:

がんワクチン,免疫チェックポイント阻害剤 (ICI),受容細胞療法,サイトカインベースの治療を含む主要な免疫療法戦略のレビュー.
腫瘍解毒ウイルス,ネオアンチゲンベースの治療法,および双種の抗体などの新しいイノベーションの検討.
免疫抑制性腫瘍マイクロ環境 (TME),バイオマーカーの制限,免疫関連の有害事象 (irAEs) を含む課題の議論.

主要な成果:

免疫療法は前立腺がんの治療に有望な先駆けとなります
アンドロゲン欠乏療法 (ADT),放射線療法,標的治療を含む組み合わせ戦略は潜在的であることを示しています.
バイオマーカー発見と人工知能 (AI) の進歩は,パーソナライズされた免疫療法にとって極めて重要です.

結論:

免疫療法を標準的な前立腺がん治療に組み込むことは患者の改善のために不可欠です
先進的な免疫療法への平等なアクセスを優先すべきです
バイオマーカーや人工知能の進歩によってパーソナライズされた治療の最適化に焦点を当てています

キーワード:

アンドロゲン欠乏療法がんワクチン化学療法免疫チェックポイント阻害剤免疫療法前立腺がん標的型療法腫瘍の微小環境

さらに関連する動画

11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.5K

関連する概念動画

01:27

Tumor Immunotherapy

660

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

660

01:30

Cancer Vaccines

509

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

509

02:49

Cancer Therapies

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.9K

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.4K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...